IMS Health Names Kevin Knightly Senior VP, Business Line Management; Adel Al-Saleh Appointed President, Europe, Middle East and Africa

IMS Health (NYSE: RX) today named Kevin Knightly senior vice president, Business Line Management, a new position. Previously, Mr. Knightly was president, Europe, Middle East and Africa (EMEA) for IMS. He continues to report to David Carlucci, IMS chairman and CEO, and will be based at the company’s headquarters in Norwalk, CT. Succeeding Mr. Knightly as president, EMEA is Adel Al-Saleh, who reports to Gilles Pajot, IMS chief operating officer. In his new role, Mr. Knightly will be responsible for leading IMS’s business lines, including sales force effectiveness, portfolio optimization, and launch and brand management. In addition, Mr. Knightly will drive IMS’s emerging payer solutions initiative. "For nearly a decade, Kevin has contributed significantly to our success in Europe, in both setting our business direction and aligning our capabilities around changing market dynamics,” said Mr. Carlucci. "With broad operational and industry experience, he understands the challenges and opportunities in global healthcare, and will ensure that we are bringing innovative, high-value offerings to clients.” With 23 years of service at IMS and its predecessor companies, Mr. Knightly has held a number of senior financial, operations, marketing and general management posts. He has served as chief financial officer for both IMS North America and Europe, and was senior vice president, Marketing and Major Markets, EMEA. Mr. Al-Saleh assumes responsibility for IMS operations in more than 50 countries in Europe, Middle East and Africa. He joined IMS in January 2007 as senior vice president, Sales and Major Markets, EMEA. Said Mr. Carlucci, "Adel’s proven leadership skills and strong client focus will be tremendous assets to IMS as we strengthen our role as a strategic partner to healthcare stakeholders across Europe. I am confident that he will continue our drive to deliver even more value for clients in the region, and growth for IMS.” Prior to joining IMS, Mr. Al-Saleh spent 19 years with IBM serving several different industries and holding a variety of roles spanning international sales, business development and executive management. He rose to the position of vice president, Sales, IBM Northeast Europe, responsible for business across all industries and brands in the IBM Northeast organization. About IMS Operating in more than 100 countries, IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.0 billion in 2006 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations, including portfolio optimization capabilities; launch and brand management solutions; sales force effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve ROI and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.